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Introduction
The development of many metazoans is programmed from
fertilization by maternal determinants in the oocyte. As a
consequence, the developmental fate of cells derived from
early embryonic divisions is restricted according to their
position in the embryo. By contrast, maternal instruction
appears to play a substantially lesser role in the mammal, in
which early development results in the formation of a
population of pluripotent cells that are not markedly restricted
in developmental potential and retain the ability to give rise to
all embryonic and adult cell types (Smith, 1992).
The first differentiation event of mouse embryogenesis
entails the elaboration of extra-embryonic lineages by
formation of trophectoderm from outer cells of the embryo.
Inner cells, which retain pluripotent differentiation capability,
form the inner cell mass (ICM) of the blastocyst. At ~4 days
post coitum (d.p.c.), ICM cells lining the blastocoelic cavity
differentiate into primitive endoderm, the precursor of extra-
embryonic lineages including visceral and parietal endoderm.
Following this differentiation, pluripotent cells within the
mouse embryo are referred to generically as the ‘epiblast’. At
around the time of implantation (4.5 d.p.c.), ICM cells
commence a complex developmental program resulting in the
formation of a second pluripotent cell population, the primitive
ectoderm. Rapid proliferation, in which cell cycles as short as
5 hours have been reported (Snow, 1977), results in expansion
of the pluripotent cell population from ~25 cells at 4.5 d.p.c.
to 660 cells by 6.5 d.p.c. (Snow, 1977). Transplantation
experiments (Beddington, 1983a) reveal alteration in the
developmental potential of pre- and post-implantation
pluripotent cells, and this is accompanied by alterations in gene
expression (Haub and Goldfarb, 1991; Hebert et al., 1991;
Rogers et al., 1991). Formation of the proamniotic cavity
within the epiblast, apparently as a result of cell apoptosis
(Coucouvanis and Martin, 1995), is accompanied by
reorganization of the pluripotent cells into a pseudostratified
epithelial monolayer. The primitive ectoderm that results from
these cellular events comprises several thousand pluripotent
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Formation and differentiation of a pluripotent cell
population is central to mammalian development, and
the isolation, identification and manipulation of human
pluripotent cells is predicted to be of therapeutic use.
Within the early mammalian embryo, two distinct
populations of pluripotent cells have been described: the
inner cell mass (ICM), which differentiates to form a
second pluripotent cell populations, the primitive
ectoderm. Indirect evidence suggests the existence of
temporally distinct intermediate pluripotent cell
populations as primitive ectoderm is formed. We coupled
an in vitro model of primitive ectoderm formation (the
transition of embryonic stem cells to early primitive
ectoderm-like (EPL) cells) with ddPCR-based techniques
to identify three novel genes, Psc1, CRTR-1 and PRCE, that
were expressed differently during pluripotent cell
progression. Detailed mapping of these genes with Oct4,
Rex1 and Fgf5 on pregastrulation embryos provided the
first molecular evidence for the existence of successive,
temporally distinct pluripotent cell populations in the
embryo between the ICM and primitive ectoderm. No
evidence was found for spatial heterogeneity within the
Oct4+ pool. The transition between populations correlated
with morphological or developmental alterations in
pluripotent cells in vivo. Genes that are temporally
expressed during pluripotent cell progression may provide
an opportunity for molecular discrimination of pluripotent
cells at different stages of maturation in vivo and an
understanding of the cellular origins and properties of
pluripotent cell lines isolated from diverse sources.
Furthermore, the strong correlation of gene expression
demonstrated between EPL cell formation in vitro and
primitive ectoderm formation in vivo validates EPL cells as
a model for primitive ectoderm, thereby providing a model
system for the investigation of pluripotent differentiation
and an opportunity for directed differentiation of
pluripotent cells to therapeutically useful cell populations.
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cells by 7.0 d.p.c. that are unspecified until at least 6.0-6.5
d.p.c. (Snow, 1977; Beddington, 1981; Beddington, 1982;
Beddington, 1983b; Lawson et al., 1991) and which, during
gastrulation, give rise to the three germ layers of the
mammalian embryo.
Pluripotent cells are receiving considerable attention owing
to the recognition that manipulation of pluripotent cell lines in
vitro might provide a route to therapeutic cell production
(Rathjen et al., 1998; Smith, 1998). Pluripotent cell lines with
different cellular origins have been reported. Of these, mouse
embryonic stem (ES) cells are stable lines that share many
properties with ICM/early epiblast cells, including the ability
to differentiate into all embryonic cell types including the germ
line (Evans and Kaufman, 1981; Martin, 1981; Rathjen et al.,
1999). Pluripotent embryonal carcinoma (EC) lines have been
derived from human and mouse teratocarcinomas (Pera et al.,
1990) and have diverse properties that may be explained by
their different cellular origins and extended deregulated growth
in vitro and in vivo. Pluripotent embryonic germ (EG) cell lines
of mouse and human origin are derived by the reversion of
primordial germ cells in vitro and share many properties with
mouse ES cells (Resnick et al., 1992; Matsui et al., 1992;
Shamblott et al., 1998). Finally, human ES cells, which are of
considerable therapeutic potential, appear to be substantially
equivalent but in several respects distinct from mouse ES cells
(Thomson et al., 1998; Reubinoff et al., 2000). The cellular
origin and identity of pluripotent cell lines are likely to affect
their growth and differentiation characteristics in vitro.
Recognition of pluripotent cell lines in vitro, identification of
their closest embryological equivalents and investigation of
their interrelationships within and across species is therefore
of considerable importance. One approach is the identification
of genes that are differently expressed within distinct
pluripotent cell populations in vivo.
Although pluripotent cells are fundamental to mammalian
embryogenesis, relatively little is known of the developmental
behaviour or molecular profile of these cells. Several lines of
evidence, including cell potency studies and the phenotypes of
mutant embryos, suggest that progression from ICM to
primitive ectoderm entails the progressive formation of
temporally distinct pluripotent cell populations (Pelton et al.,
1998). However, molecular characterization of these postulated
populations has not been possible because few markers
delineating this time in embryogenesis have been described. Of
the reported proteins, the POU domain transcription factor
Oct4 can be used to recognize all pluripotent cell populations
(Rosner et al., 1990; Scholer et al., 1990), but only the Fgf5
(Haub and Goldfarb, 1991; Hebert et al., 1991), Rex1 (Rogers
et al., 1991) and Gbx2 (Chapman et al., 1997) genes are
expressed differently in the ICM and primitive ectoderm.
Moreover, the temporal expression of these genes in the
pluripotent cell pool in vivo has only been crudely assessed.
We have previously described an in vitro culture system that
results in lineage specific differentiation of mouse ES cells to
a second pluripotent cell population termed early primitive
ectoderm-like (EPL) cells (Rathjen et al., 1999; Lake et al.,
2000). Analysis of gene expression markers, morphology,
cytokine responsiveness and differentiation potential in vivo
and in vitro suggests that EPL cells are most closely related to
cells of the embryonic primitive ectoderm. As a progressive
event, which occupies several days in vitro, the ES-EPL cell
conversion can be used to model the differentiation of ICM to
primitive ectoderm in vivo and provides a system for the
identification of differently expressed genes within pluripotent
cell populations of the ICM and primitive ectoderm. In contrast
to embryonic tissue, starting material is not limited, whereas
the homogeneity and relative synchrony of the cell transition
minimize difficulties associated with culture heterogeneity,
including persistence of undifferentiated ES cell ‘nests’, during
spontaneous ES cell differentiation in vitro (Rathjen et al.,
1990). Genes with temporally regulated expression during
differentiation of the ICM to primitive ectoderm in vivo
potentially provide a route to molecular identification of
transient pluripotent cell populations in the embryo and their
cellular equivalents in vitro. Furthermore, these genes would
enable detailed mapping of the ES-EPL cell transition in vitro
onto embryonic cell populations.
In this work, we used conventional differential display PCR
(ddPCR) (Liang and Pardee, 1992) and modified ddPCR
(internal display PCR (idPCR)) techniques to identify three
novel genes that are expressed differently in ES and EPL
cells: Periimplantation Stem Cell 1 (Psc1), Cp2-Related
Transcriptional Repressor-1 (CRTR-1) and Protein Related to
Cut1/ESP1 (PRCE). Detailed expression mapping of these
genes and the reported markers Fgf5 and Rex1 in vitro and in
vivo revealed that expression of each gene was restricted to a
temporally distinct subpopulation of pluripotent cells within
the Oct4+ pool. There was a correlation between expression
of these genes in vitro and in vivo, and between alterations
in gene expression and key developmental events in vivo.
Characterization of these genes provides direct molecular
evidence for the identification of EPL cells as like primitive
ectoderm, supports the ES-EPL cell transition as a model
for ICM to primitive ectoderm development in vivo and
confirms the formation of temporally distinct pluripotent
cell populations as the ICM differentiates to form primitive
ectoderm both in the embryo and in vitro.
Materials and Methods
Cell culture conditions and embryo collection
ES and EPL cell culture were carried out as described by Rathjen et
al. (Rathjen et al., 1999). D3 (Doetschman et al., 1985) and MBL5
(Pease et al., 1990) ES cell lines were obtained from L. Williams
(Ludwig Institute, Melbourne).
Embryos used for in situ hybridization were obtained from time-
mated Swiss females. Mice were maintained on a 12 hour light/12
hour dark cycle and supplied with food and water ad libitum. Embryo
stages are represented as d.p.c., assuming that fertilization occurred
at the midnight preceding the discovery of the vaginal plug. Isolation
and dissection of pre-implantation and post-implantation embryos
were carried out according to Hogan et al. (Hogan et al., 1994) in
dissection buffer (80% ES Dulbecco’s Modified Eagle’s Medium
(DMEM) (Gibco/BRL), 20% foetal calf serum (FCS)
(Commonwealth Serum Laboratories), 10 mM HEPES pH 7.4),
except that 5.0-5.5 d.p.c. embryos were removed from individual
implantation sites by sectioning the uterus along the mesometrial side
of the implantation site, prising open the decidua and shelling out the
embryo with sharpened watchmakers forceps.
Differential display PCR (ddPCR)
Cytoplasmic RNA was isolated using the method of Edwards et al.
(Edwards et al., 1985) from MBL5 (Psc1) or D3 (CRTR1, PRCE) ES
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cells and derivative EPL cells. EPL cells were formed and cultured
for 2, 4 and 6 days in medium supplemented with 50% MEDII or 50%
MEDII and 1000 units ml–1 LIF (Rathjen et al., 1999). EPL cells were
passaged every two days. All pluripotent cells were cultured in
gelatine-treated tissue-culture-grade plastic ware in the absence of
feeders.
For ddPCR (Liang and Pardee, 1992) and idPCR, 2 m g total RNA
was denatured at 65°C for 10 minutes and added to a 25 m l reverse
transcription reaction mix containing 50 mM Tris-HCl pH 8.5, 6 mM
MgCl2, 40 mM KCl, 1 mM DTT, 1.5 mM each dNTP, 40 U RNasin
and 15 U AMV reverse transcriptase. The ddPCR and idPCR reverse
transcription reactions were primed with 100 ng 3 ¢ anchored-oligo
d(T) primer (5¢ -ATGAATTCTTTTTTTTTTTTA/C/GN-3 ¢ ) or 250 ng
of 3¢ -hp primer (5¢ -TAGAATTCCGTNCGTAGTTCTTGAGAACCA-
3¢ ) (N represents A, C, G or T), respectively, and incubated for 1 hour
at 42°C or 50°C respectively followed by incubation at 94°C for 5
minutes.
1-2 m l of cDNA was used as template in 25 m l PCR reactions
containing 1.5 mM MgCl2, 1· Taq buffer (Geneworks), 20 m M each
dNTP, 37.5 ng arbitrary tenmer (Operon technologies), 5 m Ci [a -33P]
dATP, 1 U Taq polymerase (Geneworks) and 100 ng of 3¢ -anchored-
oligo d(T) primer (ddPCR) or 500 ng 3¢ -hp (idPCR). PCR reactions
were amplified in a MJ Research PTC-100 thermal cycler for 40 cycles
of 94°C for 1 minute, 42°C for 1 minute, 72°C for 30 seconds (ddPCR)
or 40 cycles of 94°C for 30 seconds, 42°C for 30 seconds, 72°C for
30 seconds (idPCR), followed by a final extension at 72°C for 5
minutes. PCR products were separated by electrophoresis on 6%
denaturing polyacrylamide gels and exposed to X-ray film for 1-3 days.
Selected PCR products were excised from the gel and eluted in 100
m l of 0.5 M ammonium acetate, 10 mM magnesium acetate, 1 mM
EDTA pH 8.0, 0.1% SDS at 50°C for 5-20 hours. 1 m l of eluted ddPCR
product was used directly as a template in 100 m l PCR reamplification
reactions under the same conditions as the original ddPCR or idPCR,
omitting radioactive label. Reamplified PCR products were cloned
into pBluescript KS and sequenced using T7 and T3 primers, using a
T7 DNA sequencing kit (Pharmacia).
Use of the more complex reverse transcription primer for idPCR
decreased the number of products amplified with each primer
combination but reduced the background of spurious amplification
products thereby facilitating reamplification and cloning of specific
differently expressed products.
RNA isolation and northern blot analysis
Cytoplasmic RNA was isolated from cultured cells using the method
of Edwards et al. (Edwards et al., 1985). Poly-A+ RNA was isolated
using the method of Celano et al. (Celano et al., 1993). Northern blot
analysis was carried out as described in Thomas et al. (Thomas et al.,
1995) using 25 m g total RNA or 4 m g poly-A+ RNA. DNA probes
were prepared from DNA fragments using a Gigaprime labelling kit
(Geneworks). Fragments for CRTR-1 (736 bp), Psc1 (458bp) and
PRCE (232 bp) were excised from pBluescript KS II clones by XhoI-
BamHI, BamHI-HindIII and BamHI-HindIII digestion, respectively.
Rex1, Fgf5, Oct4 and mGAP probes were as described in Rathjen et
al. (Rathjen et al., 1999). Band intensity was determined by volume
integration using ImageQuant (Molecular Dynamics)
In situ hybridization
Wholemount in situ hybridization of both cell layers and embryos was
carried out using the method of Rosen and Beddington (Rosen and
Beddington, 1993) with the following modifications. Cell layers and
3.5-5.5 d.p.c. embryos were washed in RIPA buffer three times for 20
minutes before post-fixing. Embryos were prehybridized, hybridized
and washed at 63.5°C for Psc1, 65°C for Oct4, Rex1, CRTR-1 and
PRCE and 68°C for Fgf5. The conjugate of anti-digoxygenin Fab with
alkaline phosphatase was not preabsorbed with embryo powder prior
to use in cell layer in situ hybridization. Sense and antisense CRTR-
1 digoxygenin riboprobes were generated from the pBluescript II KS
Fig. 1. IdPCR and ddPCR analysis of ES and EPL cell RNA.
(A) Cytoplasmic RNA was isolated from ES cells and EPL cells
grown for 4 or 6 days in the presence of 50% MEDII + LIF (+).
Then, 2 m g of this RNA were analysed by idPCR using the 5 ¢ primer
OPB-04 (GGACTGGAGT; Operon Technologies). PCR products
were resolved by electrophoresis on a 6% (v/v) denaturing
polyacrylamide gel. (B) Cytoplasmic RNA was isolated from ES
cells and EPL cells grown for 2, 4 or 6 days in 50% MEDII in the
presence (+) or absence (–) of LIF. Then, 2 m g of this RNA were
analysed by ddPCR using the 5¢ primer OPA-01 (CAGGCCCTTC;
Operon Technologies) PCR products were resolved by
electrophoresis on a 6% (v/v) denaturing polyacrylamide gel. Arrows
mark the indicated products.
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clone by BamHI digestion and transcription with T7 RNA
polymerase, and by XhoI digestion and transcription with T3 RNA
polymerase, respectively. Sense and antisense Psc1 digoxygenin-
labelled-riboprobes were generated from the pBluescript II KS clone
by digestion with HindIII and BamHI, respectively, and transcription
with T3 and T7 RNA polymerase, respectively. PRCE sense and
antisense digoxygenin riboprobes were generated from the
pBluescript KS II clone by BamHI digestion and transcription with
T3 RNA polymerase, and by HindIII digestion and transcription with
T7 RNA polymerase, respectively. Rex1 sense and antisense probes
were produced from an 848 bp clone in pCRÔ II (Hosler et al., 1989)
(obtained from N. Clarke) by digestion with BamHI and XbaI,
respectively, and transcription with T7 and Sp6 RNA polymerases,
respectively. Oct4 and Fgf5 probes were generated as described in
Rathjen et al. (Rathjen et al., 1999).
Results
Identification of genes expressed differently in ES and
EPL cells
Conventional ddPCR and idPCR (T. C. Schulz, PhD thesis,
Adelaide Univeristy, 1996; see Materials and Methods) were
used to investigate temporal changes in gene expression
associated with the ES-EPL cell transition. ES cells were
compared with EPL cells maintained in culture for 2, 4 and 6
days in medium containing 50% MEDII in the presence and
absence of LIF (Fig. 1). LIF has been previously shown to
retard the formation of primitive ectoderm in embryoid bodies
and EPL cells in culture (Shen and Leder, 1992; Rathjen et al.,
1999). The expression profiles of three differently expressed
products that were selected for further analysis are indicated in
Fig. 1. Psc1 was expressed in ES cells and EPL cells cultured
for 4 days in the presence of 50% MEDII + LIF and was
downregulated in EPL cells cultured in 50% MEDII + LIF for
6 days (Fig. 1A). CRTR-1 was expressed in EPL cells cultured
for 2 and 4 days in the presence or 2 days in the absence of
LIF, and was downregulated in EPL cells with further culture
in MEDII or MEDII + LIF (Fig. 1B). PRCE was expressed at
low levels in ES cells and EPL cells cultured for 2 days in 50%
MEDII or 2 and 4 days in 50% MEDII + LIF, and was
upregulated in EPL cells cultured for 4 and 6 days in 50%
MEDII or 6 days in 50% MEDII + LIF (Fig. 1B).
Expression and validation of cloned ddPCR transcripts
Differently expressed bands corresponding to CRTR1, Psc1
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Fig. 2. Expression of cloned PCR products in pluripotent cells.
(A) Northern blot analysis of 4 m g poly-A+ RNA, isolated from ES
cells and EPL cells grown for 2, 4 or 6 days in 50% MEDII in the
presence (+) or absence (–) of LIF, probed for Oct4, CRTR1, Rex1,
Psc1, Fgf5 and mGAP. Transcript sizes were: Oct4, 1.6 kb; CRTR-
1, 9.4 kb; Rex1, 1.9 kb; Psc1, 5.5 kb; Fgf5, 2.7 kb; and mGAP, 1.5
kb. (Bi) Northern blot analysis of 25 m g total RNA isolated from ES
cells and EPL cells grown for 2, 4, 6 or 8 days in 50% MEDII in
the presence of LIF (+) and probed for PRCE and mGAP
expression. Transcript sizes were: PRCE, 6.6 kb; mGAP, 1.5 kb.
(Bii) Quantitation of northern in (Bi). PRCE expression was
normalized against the mGAP loading control and expressed as a
ratio, with ES cells assigned a value of 1. (C) In situ hybridization
of ES cells (i, iii) and EPL cells cultured for 2 days in the presence
of MEDII + LIF (ii, iv) with Oct4 (i, ii) and PRCE (iii,iv) antisense
digoxygenin-labelled riboprobes. Images were captured using
Hoffmann interference contrast microscopy. Bar, 90 m m. (D) In situ
hybridization of EPL cells cultured for 4 days in the presence of
MEDII and LIF with CRTR-1 (i, ii) and PRCE (iii, iv) antisense
digoxygenin-labelled riboprobes. (i, iii) Phase contrast microscopy;
(ii, iv) bright field microscopy. Arrows denote differentiated cells.
Bar, 25 m m. Equivalent cell populations to those illustrated in C and
D were probed with digoxygenin-labelled sense probes and failed to
develop colour (data not shown).
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and PRCE were excised from gels and cloned
into pBluescript. Correct isolation and cloning
of differently expressed cDNA fragments was
confirmed by northern blot analysis. In
contrast to ddPCR-based techniques, which
may not be quantitative owing to competition
between transcripts for primer binding, this
provides a definitive and quantitative
indication of transcript expression.
Poly-A+ RNA, isolated from ES and EPL
cells cultured in 50% MEDII in the presence
or absence of exogenous LIF for 2, 4 and 6
days was analysed by northern blot for
expression of Oct4, CRTR-1, Rex1, Fgf5 and
Psc1 (Fig. 2A). PRCE expression was
confirmed by northern blot of total RNA from
ES and EPL cells after 2, 4, 6 and 8 days of
culture in 50% MEDII in the presence of LIF
(Fig. 2B). Oct4 was expressed at high levels in
ES and EPL cell cultures as described
previously (Rathjen et al., 1999), consistent
with the expression of this gene in ICM and
primitive ectoderm cells in vivo (Rosner et al.,
1990; Scholer et al., 1990; Yeom et al., 1991).
A 9.4 kb CRTR-1 transcript was produced in
ES and EPL cells cultured for 2 days in MEDII
                   Psc1 GAG AGC CGA AAG AGA GCT ATT AGT GGT TTG GAG GGG CCA CTT
                    ORF  E   S   R   K   R   A   I   S   G   L   E   G   P   L
            CLEB0336.3 10  A   A   Q   G   V   V   T   Q   P   G   S   F   R   G   
ACA AAG AAG CCT TGG CTG GGA AAA CAA GGG AAC AAC AAT CAA AGT AAA CCA GGC TTC CTG
 T   K   K   P   W   L   G   K   Q   G   N   N   N   Q   S   K   P   G   F   L
 A   P   R   G   R   G   N   I   R   G   R   G   G   F   A   R   G   G   F   T
AGG AAG AAT CAT TAT ACA AAC ACC AAA CTA GAG GTG AAA AAA ATC CCC CAG GAA TTG AAC
 R   K   N   H   Y   T   N   T   K   L   E   V   K   K   I   P   Q   E   L   N
 G   A   I   N   R   D   N   C   T   L   Q   V   A   K   I   P   P   E   M   N
AAC ATT ACC AAG CTC AAC GAA CAC TTC AGC AAA TTT GGA ACC ATA GTT AAT ATC CAG GTT
 N   I   T   K   L   N   E   H   F   S   K   F   G   T   I   V   N   I   Q   V
 T   I   A   K   L   N   E   H   F   A   T   F   G   T   V   D   N   I   Q   V
GCT TTT AAG GGT GAT CCA GAA GCA GCA CTC ATC CAA TAC CTT ACC AAT GAA GAG GCC AGG
 A   F   K   G   D   P   E   A   A   L   I   Q   Y   L   T   N   E   E   A   R
 R   Y   N   G   E   I   D   S   A   L   V   T   Y   A   S   K   F   D   A   G
AAA GCC ATT TCT AGC ACA GAA GCA GTT TTG AAC AAT CGG TTC ATT CGA GTC CTG TGG CAT
 K   A   I   S   S   T   E   A   V   L   N   N   R   F   I   R   V   L   W   H
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      Psc3     CAGGCCCTTCGACTCAAGTACCTCATTGGTGCTGCACCTGTA--CTACGGCCTACCTATC   58
               :: :: :  ::::::::::: :: ::::: ::::::::: ::  ::: ::: : ::: ::
  KIAA0165     CAAGCTCCCCGACTCAAGTATCTTATTGGGGCTGCACCTATAGCCTATGGCTTGCCTGTC 6489
      Psc3     TCTCTGCAG--ACACCCTGAAGCTGTCTTGTCTATGGTAGAAGCTGTGTGAC-----TAC  111
               ::::::: :  :: :: :: ::::::::: :  ::: :::::::    : ::     :::
  KIAA0165     TCTCTGCGGTAACCCCATGGAGCTGTCTTATTGATGCTAGAAGCCTCATAACTGTTCTAC 6549
 
      Psc3     CTCCAAACTTGGTTTTGATTATT--TAGAA--TTTTTAAAGTGATTTTCCCTGGTGTTTT  167
               ::::::  :: : ::: ::  ::   : ::   ::::::::::::::::::  :::::::
  KIAA0165     CTCCAAGGTTAGATTTAATCCTTAGGATAACTCTTTTAAAGTGATTTTCCCCAGTGTTTT 6609
 
      Psc3     GTATGAAATATTTTC-TTTAATGTGACC-----TTAATAAAGATATTCCAGGC         214
                ::::::: :::: : ::: :: : :::      :::::::::::   ::   







Fig. 3. Sequence and analysis of PRCE and Psc1.
(A) Alignment of the PRCE ddPCR product
sequence with the KIAA0165 cDNA sequence.
(B) Alignment of the Psc1 idPCR product
nucleotide sequence and open reading frame
(ORF) with the predicted C. elegans ORF
CELB0336.3.
Fig. 4. Definition of embryonic stages and
identification of pluripotent cell populations
by analysis of Oct4 expression. Whole
mount in situ hybridization analysis of 4.5
d.p.c. (A), 4.75 d.p.c. (B), 5.0 d.p.c.
(C), 5.25 d.p.c. (D) and 5.5 d.p.c.
(E) mouse embryos using antisense
digoxygenin-labelled Oct4 riboprobes.
(F) A 5.0 d.p.c. embryo analysed by whole
mount in situ hybridization using antisense
digoxygenin-labelled PRCE riboprobes.
(G) A 5.25 d.p.c. embryo and (H) a 5.5
d.p.c. embryo analysed by whole mount in
situ hybridization using sense digoxygenin-
labelled PRCE riboprobes. (F-H) These
images are included to illustrate the
formation of the proamniotic cavity (PAC)
and pseudostratified epithelial layer of
primitive ectoderm (PE). Abbreviations:
EEE, extra-embryonic ectoderm; ICM,
inner cell mass; TE, trophectoderm; TGC,
trophoblast giant cells; VEn, visceral
endoderm. Bar, 50 m m. The colouration in
the trophectoderm of the 4.5 d.p.c.
blastocyst is not cellular but can be
attributed to a shadow rather than gene
expression.
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or 2 and 4 days in MEDII + LIF, and was downregulated with
EPL cell culture to undetectable levels after culture for 4 days
in the absence of LIF or 6 days in the presence of LIF. Rex1
was also expressed at highest levels in ES cells and
downregulated during EPL cell culture, with kinetics
indistinguishable from those of CRTR-1. A 5.5 kb Psc1
transcript was detected in ES and EPL cells cultured for 2 days
in the absence of LIF, or for 2 and 4 days in the presence of
LIF. In comparison with both CRTR-1 and Rex1, expression of
this gene persisted longer in EPL cells, with low but detectable
levels of expression in EPL cells cultured for 4 days in the
absence of LIF and downregulation to very low levels only
being observed on day 6 in both the presence and absence of
LIF. Fgf5 expression could not be detected in ES cells but was
upregulated in EPL cells cultured for 4 days in the presence
and 2 days in the absence of LIF, with a further increase in
expression after culture of EPL cells for 6 and 4 days,
respectively. A 6.6 kb PRCE transcript was detected in ES and
EPL cells. Expression was upregulated upon formation of EPL
cells, with a peak of expression 1.7 times that seen in ES cells
seen after culture for 4 days in 50% MEDII + LIF (Fig. 2B).
Further culture in 50% MEDII + LIF resulted in a
downregulation of PRCE expression. In situ hybridization of
ES and EPL cells with antisense digoxygenin-labelled probes
specific for PRCE and Oct4 confirmed the upregulation of
PRCE expression between ES and EPL cells cultured for 2
days (Fig. 2C).
Different expression of pluripotent cell markers during the
ES-EPL cell transition was consistent with previous results
(Rathjen et al., 1999) and with the patterns predicted by ddPCR
analysis. Temporally distinct populations of pluripotent cells
subdividing the Oct4+ population could be identified during the
differentiation of ES to EPL cells by the expression of different
combinations of genes.
ES and EPL cell cultures can be contaminated by low levels
of differentiated cells (Rathjen et al., 1999), generally located
at the periphery of colonies. Expression of CRTR-1, Psc1 and
PRCE was shown to be associated with pluripotent cells by in
situ hybridization to ES and EPL cell monolayers in vitro using
antisense digoxygenin-labelled probes. Expression of these
genes was associated with most cells in the culture, located
centrally within colonies and exhibiting a pluripotent cell
morphology (Rathjen et al., 1999). Sporadic differentiated cells
within the cultures did not express CRTR-1, Psc1 or PRCE
(Fig. 2D; data not shown).
Sequence of cDNAs
The CRTR-1, Psc1 and PRCE cDNA fragments in pBluescript
were sequenced in both directions, revealing sizes of 736 bp,
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Fig. 5. Expression of CRTR-1,
Rex1 and Psc1 during early mouse
embryogenesis. Analysis of
CRTR-1 (A), Rex1 (B) and Psc1
(C) expression by whole mount in
situ hybridization of 3.5-5.5 d.p.c.
mouse embryos using antisense
digoxygenin-labelled riboprobes.
Bar, 50 m m. Display of two
embryos at a given time point
indicates inconsistent expression,
interpreted as marking the time of
downregulation.
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458 bp and 232 bp, respectively. The CRTR-1 and PRCE
cDNAs were isolated using a 3 ¢ -anchored-oligo (dT) primer
and potentially represent 3 ¢ UTR sequence in these large
transcripts. Further analysis of CRTR-1 cDNA and the
biochemical properties of CRTR-1 has revealed homology to
the CP2 family of transcription factors (Rodda et al., 2001)
(accession number AF311309). Analysis of PRCE revealed
71.3% identity with the human cDNA KIAA0165 (Fig. 3A),
isolated from the immature myeloid cell line KG-1 (Nagase et
al., 1996). Additional sequence data and analysis suggest
functional equivalence with fungal separins and a role in
chromosome segregation (T. A. Pelton, PhD thesis, Adelaide
University, 2000). The Psc1 cDNA fragment, which was
isolated by idPCR, contained an uninterrupted open reading
frame with a region homologous (44.8% identity) to the
predicted CELB0336.3 open reading frame from
Caenorhabditis elegans (Wilson et al., 1994) (accession
number U32305; Fig. 3B). Sequence homologies and
immunocytochemical analysis of protein localization in
transfected cells indicate that Psc1 is a member of the SR
protein family with a role in RNA metabolism (S. J. Kavanagh,
Honours thesis, Adelaide University, 1998).
Expression of genes in pluripotent cell populations in
vivo
Stage definition and Oct4 expression
The predicted range of expression of marker genes used in this
analysis is defined by the ES-EPL cell transition and
encompasses the pluripotent cells of the blastocyst ICM (3.5
d.p.c.) to the primitive ectoderm of the egg cylinder at 5.5 d.p.c.
(Rathjen et al., 1999). The timing of these stages of
development vary between mouse strains and individual
embryos within a litter show some heterogeneity in
developmental progression. Accordingly, the stages of
embryogenesis were defined by morphological criteria.
Representative staged embryos between 4.5 d.p.c. and 5.5
d.p.c. stained for the pluripotent cell marker Oct4 are presented
in Fig. 4 to illustrate the embryonic cell populations.
The 3.5 d.p.c. blastocyst has an ICM partitioned to one end
of the blastocoelic cavity but no evidence of primitive
endoderm. Later blastocysts (4.0 d.p.c.) were identified by the
presence of a primitive endoderm layer. Embryos at 4.5 d.p.c.
(expanded blastocyst; Fig. 4A) had hatched from the zona
pellucida and assumed an enlarged, ovoid morphology
containing a compacted pluripotent cell population. Late-stage
blastocysts (4.75 d.p.c.; Fig. 4B) were identified by two
criteria: formation of migratory primary trophoblast giant cells
and an expanded epiblast population. Embryos at 5.0 d.p.c.
were characterized by the displacement of pluripotent cells to
fill the blastocoelic cavity, resulting in loss of a discernible
cavity (Fig. 4C). Formation of a proamniotic cavity within the
pluripotent cells was used to identify embryos later than 5.0
d.p.c. Cavity formation is first evident at 5.25 d.p.c. (Fig. 4D)
and is followed by polarization and reorganization of the
pluripotent cells into a pseudostratified epithelial sheet of
primitive ectoderm by 5.5 d.p.c. (Fig. 4E). Post-proamniotic
cavity embryos were also staged on the size of the proamniotic
cavity and arrangement of the pluripotent cells. As reported
previously (Rosner et al., 1990; Scholer et al., 1990; Yeom et
al., 1991), Oct4 transcripts were not detected at any of these
stages in trophectodermal derivatives or derivatives of the
primitive endoderm.
In vivo expression of Psc1, CRTR-1, PRCE, Rex1 and
Fgf5
Flushed pre- and early post-implantation embryos (to ~4.75
d.p.c.) or dissected post-implantation embryos were examined
for gene expression by whole mount in situ hybridization.
Fig. 6. Expression of PRCE and Fgf5 during early
mouse embryogenesis Analysis of PRCE (A) and Fgf5
(B) expression by whole mount in situ hybridization of
3.5-5.5 d.p.c. mouse embryos using antisense
digoxygenin-labelled riboprobes. Bar, 50 m m. Display
of two embryos at a given time point indicates
inconsistent expression, interpreted as marking the time
of upregulation.
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To allow detailed mapping of expression during this
experimentally difficult period, embryos were isolated at ~0.25
d.p.c. intervals.
CRTR-1 expression (Fig. 5A) was detected uniformly in
pluripotent cells of the 3.5 d.p.c. embryo and 4.5 d.p.c.
expanded blastocyst. Expression was inconsistent and at low
levels in 4.75 d.p.c. embryos, suggesting downregulation of the
gene at this time. CRTR-1 transcripts were not detected in
pluripotent cell populations of the 5.0 d.p.c. or 5.25 d.p.c.
embryo, or in extra-embryonic cell types from the
trophectodermal or primitive endoderm lineages at any of the
stages analysed.
Consistent with their jointly regulated expression in vitro,
the expression pattern of Rex1 in pluripotent cells in vivo was
equivalent to that of CRTR-1. Rex1 expression was detected in
all pluripotent cells at 3.5 d.p.c., extending the findings of
Rogers et al. (Rogers et al., 1991) who demonstrated
expression at 4.5 d.p.c. Rex1 expression persisted within all
pluripotent cells at 4.5 d.p.c. but was downregulated at ~4.75
d.p.c. and was not detected subsequently in pluripotent cells of
the embryo (Fig. 5B). Rex1 expression was not observed in
trophectoderm or primitive endoderm derived extra-embryonic
lineages up to 4.75 d.p.c., but this gene was subsequently
expressed at low levels in the extra-embryonic ectoderm
following proamniotic cavitation at 5.25 d.p.c. This expression
presumably persists until 6.0 d.p.c., as described previously
(Rogers et al., 1991).
Psc1 was found to be expressed within the pluripotent cell
pool in a pattern overlapping but distinct from those of CRTR-
1 and Rex1 (Fig. 5C). Early embryonic expression was
observed in all pluripotent cells but not trophectodermal cells
of the 3.5 d.p.c. blastocyst and was maintained in the
compacted epiblast of the expanded blastocyst at 4.5 d.p.c. In
contrast to CRTR-1 and Rex1, Psc1 transcripts were detected
uniformly throughout cells of the epiblast at 4.75 d.p.c. and
at lower, variable levels in pluripotent cells at 5.0 d.p.c.,
immediately prior to proamniotic cavity formation. Expression
was downregulated in pluripotent cells immediately following
the earliest morphological evidence of proamniotic cavitation,
a later stage than downregulation of CRTR-1 and Rex1, and was
not observed in later stage embryos that contained larger
proamniotic cavities. Psc1 expression was not detected in
primitive endoderm or other extra-embryonic cell types.
Expression of PRCE was not detected by whole mount in
situ hybridization in 3.5 d.p.c. (not shown) and 4.5 d.p.c.
embryos (Fig. 6A). Low level expression was first detected
throughout the pluripotent cell pool at 4.75 d.p.c. and higher
levels of expression were apparent in pluripotent cells of 5.0
d.p.c. embryos. PRCE expression persisted within pluripotent
cells at 5.25 d.p.c., after formation of the proamniotic cavity.
Expression in the extra-embryonic ectoderm at 5.25 d.p.c. was
also noted. PRCE expression was not detected following
polarization and reorganization of primitive ectoderm into a
columnar epithelial sheet at 5.5-5.75 d.p.c.
Although Fgf5 has been shown to be expressed in
pluripotent cells of the primitive ectoderm at 5.25 d.p.c. but not
ICM cells at 3.5 d.p.c. (Haub and Goldfarb, 1991; Hebert et
al., 1991), the timing of upregulation has not been mapped
closely. In this study, Fgf5 expression was not detected in the
pluripotent cell populations of the embryo up to 4.75 d.p.c.,
although an unexpected observation was the detection of Fgf5
expression in primitive endoderm at 4.75 d.p.c. (Fig. 6B) in 8
of the 21 embryos analysed. Expression of Fgf5 in pluripotent
cells was observed throughout the population following the
initiation of proamniotic cavitation at 5.25-5.5 d.p.c., but not
in extra-embryonic tissues at this stage. Expression of Fgf5
continues in the primitive ectoderm until the onset of
gastrulation (not shown) (Haub and Goldfarb, 1991; Hebert et
al., 1991).
Discussion
Gene expression analysis reveals temporally distinct
pluripotent cell subpopulations
Oct4 was expressed in all pluripotent cell populations
examined, consistent with previous results in vitro and in vivo
(Rosner et al., 1990; Scholer et al., 1990; Yeom et al., 1991;
Rathjen et al., 1999), and the apparent requirement for this
transcription factor in pluripotent cell maintenance (Nichols et
al., 1998). Within the Oct4+ pool, however, progressive but
distinct pluripotent cell gene expression patterns could be
identified. Cells of the 3.5 d.p.c. and 4.5 d.p.c. blastocyst and
ES cells (in vitro) expressed Oct4, CRTR-1, Rex1 and Psc1, but
not Fgf5. Although PRCE was expressed at low levels in the
ES cell population, no expression was detected in the ICM
population of the embryo. Downregulation of CRTR-1 and
Rex1 at ~4.75 d.p.c. provided molecular evidence for transition
of the pluripotent cell population. This transition was
accompanied by maintenance of Oct4 and Psc1 expression,
and initiation of PRCE expression. Interestingly, this stage of
embryogenesis was also characterized by upregulation of Fgf5
expression in extra-embryonic endoderm.
Expression of Psc1 in the absence of CRTR-1 and Rex1
identified a subsequent pluripotent cell population present
between 4.75 d.p.c. and the onset of proamniotic cavitation.
Downregulation of Psc1 expression between 5.0 d.p.c. and
5.25 d.p.c., and expression of Fgf5 resulted in a population of
pluripotent cells that expressed Oct4, PRCE and Fgf5, and was
succeeded, following downregulation of PRCE expression
between 5.25 d.p.c. and 5.5 d.p.c., by a pluripotent cell
population expressing Oct4 and Fgf5. This expression pattern
is maintained in pluripotent cells until gastrulation (Haub and
Goldfarb, 1991; Yeom et al., 1991).
The existence of temporal intermediate pluripotent cell
populations in vivo, which differ from preceding and following
pluripotent cell populations, can therefore be demonstrated by
different gene expression. This is perhaps best illustrated by
the expression of PRCE, which was expressed in pluripotent
cells in a brief developmental window between 4.75 d.p.c. and
5.25 d.p.c. Whereas pluripotent cell populations exhibited the
anticipated temporal heterogeneity in gene expression, no
evidence was obtained for spatial heterogeneity within the
pluripotent cell pool. This is consistent with the demonstration
that spatially distinct pluripotent cells in 5.5 d.p.c. and 6.5
d.p.c. embryos are not committed to alternate developmental
fates (Beddington, 1981; Beddington, 1982; Beddington,
1983b; Lawson et al., 1991).
Alterations in pluripotent cell gene expression correlate
with developmental events
The delineation of temporally distinct pluripotent cell
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populations in vivo points to a gradual transition between the
ICM and primitive ectoderm. This stage of mouse
embryogenesis is characterized by morphologically
identifiable developmental events that correlate closely with
the alterations in gene expression. A major change in
pluripotent cell gene expression was mapped at ~4.75 d.p.c.,
when CRTR-1 and Rex1 were downregulated, apparently
simultaneously, and PRCE expression was initiated. This
coincides with an embryological transition from slow cell
division within the oviduct with no overall increase in embryo
size to a rapid increase in the growth rate of the embryo,
particularly within the pluripotent cells between 4.5 d.p.c. and
5.5 d.p.c. (Snow, 1977; Hogan et al., 1994). A number of null
mutant embryos, including Fgf4 (Feldman et al., 1995), Fgfr2
(Armand et al., 1998), Brca1 (Hakem et al., 1996; Liu et al.,
1996; Ludwig et al., 1997), b 1 integrin (Fassler and Meyer,
1995; Stephens et al., 1995) and EGFR (Threadgill et al.,
1995), degenerate following implantation as a result of
impaired pluripotent cell proliferation. Different phenotypes
suggest the involvement of several signalling pathways at this
time. Alterations in Rex1, CRTR-1 and PRCE expression may
be responsive to extracellular signals regulating this phase of
peri-implantation pluripotent cell development, such as
members of the FGF family (Feldmen et al., 1995; Armand et
al., 1998). The unexpected expression of Fgf5 in primitive
endoderm at 4.75 d.p.c., as reported in this work, provides a
potential source of these signals, consistent with a
hypothesized instructive role for this extra-embryonic cell type
in the blastocyst (Thomas et al., 1998).
In similar manner, downregulation of Psc1 expression
coincided with formation of the proamniotic cavity, a process
thought to be regulated by the combined action of a diffusible
‘death’ signal secreted by visceral endoderm and a matrix-
associated ‘survival’ signal (Coucouvanis and Martin, 1995)
and downregulation of PRCE expression correlated with
reorganization of pluripotent cells into a sheet of
pseudostratified epithelium in vivo. Transcriptional analysis of
differently expressed pluripotent cell markers may therefore
provide a means for identification of the cellular origin and
timing of important embryonic signals.
Identification of pluripotent cell populations in vitro
Gene expression specific for ES cells, as assessed by expression
of Oct4, CRTR-1, Rex1 and Psc1, and lack of Fgf5, was
consistent with gene expression in pluripotent cells in vivo
between 3.5 d.p.c. and 4.75 d.p.c. Although early results have
commonly been interpreted as suggesting an embryonic origin
for ES cells in pre-implantation embryos, it has recently been
demonstrated that ES cell lines can be isolated from peri-
implantation embryos with greater efficiency (Brook and
Gardner, 1997). Although our results are consistent with either
an early or a late embryonic equivalent to ES cells, the gene
expression pattern described in this work provides a latest time
point for the embryonic equivalent at ~4.5 d.p.c. This is
consistent with the demonstration that pluripotent cells from
post-implantation embryos do not contribute to chimaeras
following blastocyst injection (Beddington, 1983a). Expression
of genes such as Rex1 and CRTR-1, if conserved across species,
could provide superior markers for the identification of ES cell
equivalents in the embryos of diverse species.
Although expression of the PRCE gene was tightly regulated
in vivo, PRCE expression in vitro appeared to be less tightly
regulated with low level expression detected in ES cells by
ddPCR, northern blot and in situ hybridization. Co-expression
in ES cells of Rex1 and CRTR-1 with PRCE is inconsistent with
our descriptions of pluripotent cells in vivo and may be
associated with the rapid proliferation exhibited by ES cells in
culture and pluripotent cells of the peri-implantation embryo
or simply reflect deregulated gene expression associated with
growth in vitro.
Although there is some variability in the rate of ES-EPL cell
transition, the temporal regulation of gene expression
described in pluripotent cells in vivo was recapitulated in this
in vitro system, supporting our previous identification of late
EPL cells as representative of early primitive ectoderm
(Rathjen et al., 1999). EPL cells cultured for 4 days in the
presence of LIF or 2 days in the absence of LIF demonstrated
a gene expression pattern analogous to pluripotent cells of the
4.75 d.p.c. embryo in which expression of CRTR-1 and Rex1
was reduced and PRCE increased. EPL cells cultured for 4
days in the absence or 6 days in the presence of LIF shared
gene expression with pluripotent cells of the 4.75-5.0 d.p.c.
embryo, which express Psc1 and PRCE but not CRTR-1 or
Rex1. EPL cells cultured for 6 days in the absence of LIF
demonstrated downregulated Psc1 expression but retained high
level expression of Fgf5 and therefore expressed a repertoire
of genes analogous to primitive ectoderm populations
occurring ~5.25 d.p.c. Downregulation of PRCE expression
was slow in vitro, in contrast to the tight regulation of this gene
between 4.75 d.p.c. and 5.25 d.p.c. in vivo. This may reflect
the lack in vitro of three-dimensional architecture required for
epithelialization. In general, the developmental progression in
vitro was significantly slower than that observed in vivo. This
is common to many cell culture systems and presumably
reflects absence of an optimal environment for developmental
progression in vitro.
Analysis of genes expressed differently between ES and
EPL cells therefore allowed the definitive identification of
previously unidentified pluripotent cell populations. These
populations may share properties with some of the diverse
pluripotent cell lines that have been isolated from non-mouse
mammalian species (Thomson et al., 1998; Reubinoff et al.,
2000) and non-ICM pluripotent cell sources (Pera, 1990;
Resnick et al., 1992; Matsui et al., 1992; Shamblott et al.,
1998). Molecular characterization of these populations with
Psc1, CRTR-1 and PRCE allowed a close alignment of in vivo
populations and EPL cells, and demonstrated that, after 6-8
days in culture, EPL cells share a gene expression profile with
5.25 d.p.c. primitive ectoderm. EPL cells cultured for less than
6-8 days could be aligned with temporal pluripotent
intermediates formed in the embryo between 4.5 d.p.c. and
5.25 d.p.c. The ability to generate a homogeneous population
in culture equivalent to primitive ectoderm provides a substrate
for the development of model systems for the investigation of
pluripotent cell differentiation, and may provide a starting
point for the development of procedures for directed cell
differentiation and production of cell populations with
therapeutic applications from pluripotent cells.
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